Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress Life Science Investing
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models Life Science Investing
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 Life Science Investing
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing Life Science Investing
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November Life Science Investing
NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing Life Science Investing
UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting Life Science Investing
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology Annual Meeting Life Science Investing
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting Life Science Investing
Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell Therapy Data at ASH 2025 Life Science Investing
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition Life Science Investing
